Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.10 per share
-
Shares outstanding
-
1,147,663,152
-
Total 13F shares
-
530,793,870
-
Share change
-
-45,021,935
-
Total reported value
-
$9,338,408,413
-
Put/Call ratio
-
192%
-
Price per share
-
$17.60
-
Number of holders
-
511
-
Value change
-
-$1,109,533,807
-
Number of buys
-
216
-
Number of sells
-
374
Institutional Holders of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) as of Q3 2017
As of 30 Sep 2017,
TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) was held by
511 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
530,793,870 shares.
The largest 10 holders included
FRANKLIN RESOURCES INC, Capital Research Global Investors, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., FMR LLC, HIGHFIELDS CAPITAL MANAGEMENT LP, Northern Cross, LLC, ABRAMS CAPITAL MANAGEMENT, L.P., Bank of New York Mellon Corp, and ALLIANCEBERNSTEIN L.P..
This page lists
513
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.